0001209191-19-039454.txt : 20190628 0001209191-19-039454.hdr.sgml : 20190628 20190628152526 ACCESSION NUMBER: 0001209191-19-039454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190628 FILED AS OF DATE: 20190628 DATE AS OF CHANGE: 20190628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Scott Andrew CENTRAL INDEX KEY: 0001614975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 19929040 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-28 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001614975 Smith Scott Andrew C/O SPRING BANK PHARMACEUTICALS, INC. 35 PARKWOOD DRIVE HOPKINTON MA 01748 1 0 0 0 Common Stock 2019-06-28 4 P 0 12000 4.09 A 13883 D This transaction was executed in multiple trades at prices ranging from $3.94 to $4.10 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Lori Firmani, attorney-in-fact 2019-06-28